Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Newpath Management

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 9
Average round size
info
The average size of a deal this fund participated in
$105M
Portfolio companies 7
Rounds per year 2.25
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity
Seed

Areas of investment

  • Biotechnology
  • Medical
  • Health Care
  • Life Science
  • Pharmaceutical

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anniston Capital New York, New York, United States
ClearVue Partners China, Shanghai, Shanghai
Fluid Vehicle Owners -
Galileo Ventures China, Shanghai
Harbright Ventures North Carolina, Raleigh, United States
Healthcare Co-op California, San Francisco, United States
HY Capital Changning, China, Shanghai
Montiko GmbH Baden-Wurttemberg, Germany, Karlsruhe
NatWest Markets England, London, United Kingdom
Paraca Japan, Tokyo
Praetorian Financial Group (PFG) New York, New York, United States
Prime Holdings -
Promus Equity Partners Chicago, Illinois, United States
Qianhai Daren China, Guangdong, Shenzhen
Shenzhen Qianhai Rengong Zhineng Liuhao Touzi China, Guangdong, Shenzhen
Space Expedition Corporation (SXC) Amsterdam, Noord-Holland, The Netherlands
Tribune Ventures Chicago, Illinois, United States
UniqueLab Japan, Tokyo
UST Aliso Viejo, California, United States
Wellspring Investments -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Orbital Therapeutics

Biotechnology
07 Sep 2022 -

Neumora Therapeutics

Biotechnology
Health Care
Medical
$400M07 Oct 2021 Watertown, Massachusetts, United States

Exo Therapeutics

Biotechnology
Health Care
Pharmaceutical
$78M05 Oct 2021 Cambridge, Massachusetts, United States

Seventh Sense Biosystems

Biotechnology
Diagnostic Equipment
Health Care
Health Diagnostics
$21M03 Sep 2021 Cambridge, Massachusetts, United States

Prime Medicine

Biotechnology
Medical
$200M13 Jul 2021 Cambridge, Massachusetts, United States

Kojin Therapeutics

Biopharma
Biotechnology
Life Science
Medical
$60M09 Jun 2021 Cambridge, Massachusetts, United States

Myeloid Therapeutics

Biotechnology
Life Science
$50M06 Jan 2021 Cambridge, Massachusetts, United States

Exo Therapeutics

Biotechnology
Health Care
Pharmaceutical
$25M16 Dec 2020 Cambridge, Massachusetts, United States

Prime Medicine

Biotechnology
Medical
$115M22 Oct 2019 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Newpath Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: